Showing results (41-50 of 185) with videos related to
Sort By:
Pageof 19
Pain Medicine (Malden, Mass.)|August 27, 2015
Is levorphanol a better option than methadone?Thien C Pham, Jeffrey Fudin, Robert B RaffaNeuroscience Letters|September 3, 2003
kappa-Opioid withdrawal in PlanariaRobert B Raffa, Gregory W Stagliano, Sumiyo UmedaAdvances in Therapy|January 19, 2013
Tapentadol extended release for chronic pain patientsRobert Taylor, Joseph V Pergolizzi, Robert B RaffaPain Management Nursing : Official Journal of the American Society of Pain Management Nurses|March 8, 2014
Treating acute pain in light of the chronification of painJoseph V Pergolizzi, Robert B Raffa, Robert TaylorJournal of Clinical Pharmacy and Therapeutics|February 23, 2019
Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactionsRobert B Raffa, Robert Taylor, Joseph V PergolizziJournal of Pain Research|May 10, 2012
Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literatureRobert Taylor, Robert B Raffa, Joseph V PergolizziAdvances in Therapy|June 1, 2015
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute PainJoseph V Pergolizzi, Robert Taylor, Robert B RaffaExpert Opinion on Drug Safety|November 12, 2013
Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?Robert B Raffa, Robert Taylor, Joseph V PergolizziExpert Opinion on Drug Safety|July 21, 2009
Considerations on the use of oxymorphone in geriatric patientsJoseph V Pergolizzi, Robert B Raffa, Errol GouldPharmaceutical Research|November 1, 2011
'Null method' determination of drug biophase concentrationRonald J Tallarida, Neil Lamarre, Robert B RaffaPageof 19